Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How CLSPN could demystify its prognostic value and potential molecular mechanism for hepatocellular carcinoma: A crosstalk study
Yanlong Shi, Yizhu Wang, Kaiyi Niu, et al.
Computers in Biology and Medicine (2024) Vol. 172, pp. 108260-108260
Closed Access | Times Cited: 17

Showing 17 citing articles:

Leveraging Non‐Radiative Transitions in Asphaltenes‐Derived Carbon Dots for Cancer Photothermal Therapy
Ozioma Udochukwu Akakuru, Jie Xing, Shuqi Huang, et al.
Small (2024)
Open Access | Times Cited: 6
Predictive Efficacy of the Advanced Lung Cancer Inflammation Index in Hepatocellular Carcinoma After Hepatectomy
Xin Qiu, Shuang Shen, Donghong Lu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 5197-5210
Open Access | Times Cited: 5
Cancer-associated fibroblast-derived exosomes in cancer progression: a focus on hepatocellular carcinoma
Chou‐Yi Hsu, Abdulrahman T. Ahmed, Safia Obaidur Rab, et al.
Experimental Cell Research (2025), pp. 114424-114424
Closed Access
Comprehensive analysis of mitochondrial solute carrier family 25 (SLC25) identifies member 19 (SLC25A19) as a regulatory factor in hepatocellular carcinoma
Xueke Gao, Yangtao Xu, Xinyao Hu, et al.
Gene (2025), pp. 149299-149299
Closed Access
Evaluation of serum ESPL1 as a biomarker for early diagnosis of HBV-related hepatocellular carcinoma
Lu-Huai Feng, Lu Wei, Bobin Hu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Prognostic Value of Inflammatory Markers in HBV-Related HCC After Hepatectomy Based on a Clinical Database
Tao Zhou, Jiongze Fang, Jing Huang, et al.
Journal of Investigative Surgery (2025) Vol. 38, Iss. 1
Open Access
Potential of CLSPN as a therapeutic target in melanoma: a key player in melanoma progression and tumor microenvironment
Yongyi Xie, Ruoqi Wang, Mingyuan Xu, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Prognostic Impact of Metabolic Syndrome and Steatotic Liver Disease in Hepatocellular Carcinoma Using Machine Learning Techniques
Sergio Gil-Rojas, Miguel Suárez, Pablo Martínez-Blanco, et al.
Metabolites (2024) Vol. 14, Iss. 6, pp. 305-305
Open Access | Times Cited: 1
Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study
Xulin Liu, Zhan-Cheng Qiu, Elijah Ndhlovu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1127-1141
Open Access | Times Cited: 1
Engineered Biomimetic Nanovesicles Synergistically Remodel Folate-Nucleotide and γ-Aminobutyric Acid Metabolism to Overcome Sunitinib-Resistant Renal Cell Carcinoma
Minchao Lv, Bin Liu, Yi Duan, et al.
ACS Nano (2024)
Closed Access | Times Cited: 1
Hispolon-loaded lipid nanocapsules for the management of hepatocellular carcinoma: comparative study with solid lipid nanoparticles and suspension
Nabil K. Alruwaili, Waleed Hassan Almalki, Salem Salman Almujri, et al.
Nanomedicine (2024), pp. 1-22
Closed Access | Times Cited: 1
The immunomodulatory role of the MAFB gene in hepatocellular carcinoma and its impact on biological activities
Yijun Zhou, Tao Meng, Li Zhang, et al.
Gene (2024) Vol. 934, pp. 149030-149030
Open Access | Times Cited: 1
Dual Responsive Magnetic DCR3 Nanoparticles: A New Strategy for Efficiently Targeting Hepatocellular Carcinoma
Lina Jia, Yuguo Dai, Yingchen Xu, et al.
Small (2024)
Closed Access | Times Cited: 1
miR‐542‐5p targets GREM1 to affect the progression of renal fibrosis
Shuting Pang, Boji Xie, Bingmei Feng, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 9
Open Access
The interdisciplinary approach to investigate bona fide agent(s) in flavonoids or alkaloids in treating HCC
Ki‐Kwang Oh, Sang‐Jun Yoon, Seol Hee Song, et al.
Artificial Cells Nanomedicine and Biotechnology (2024) Vol. 52, Iss. 1, pp. 500-511
Open Access
Intraperitoneal and Extraperitoneal Pringle Hepatic Hilar Occlusion in Laparoscopic Liver Resection: A Prospective Randomized Controlled Study
Liang He, Weixiang Li, Dachen Zhou, et al.
Current Medical Science (2024) Vol. 44, Iss. 6, pp. 1210-1216
Closed Access
Noninvasive biomarkers implicated in urea and TCA cycles for metabolic liver disease
Guiyan Yang, Yu-Jui Yvonne Wan
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Page 1

Scroll to top